Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial
Tóm tắt
Từ khóa
Tài liệu tham khảo
2001, Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation, N Engl J Med, 345, 494, 10.1056/NEJMoa010746
Rothberg, 2005, Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit, Ann Intern Med, 143, 241, 10.7326/0003-4819-143-4-200508160-00005
Wallentin, 2003, Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial, Lancet, 362, 789, 10.1016/S0140-6736(03)14287-0
Kubitza, 2005, Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939—an oral, direct Factor Xa inhibitor—after multiple dosing in healthy male subjects, Eur J Clin Pharmacol, 61, 873, 10.1007/s00228-005-0043-5
Eriksson, 2008, Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty, N Engl J Med, 358, 2765, 10.1056/NEJMoa0800374
Lassen, 2008, Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty, N Engl J Med, 358, 2776, 10.1056/NEJMoa076016
Kakkar, 2008, Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial, Lancet, 372, 31, 10.1016/S0140-6736(08)60880-6
Turpie, 2009, Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial, Lancet, 373, 1673, 10.1016/S0140-6736(09)60734-0
Antman, 2000, The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making, JAMA, 284, 835, 10.1001/jama.284.7.835
Cohen, 1994, Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users: primary end points analysis from the ATACS Trial, Circulation, 89, 81, 10.1161/01.CIR.89.1.81
Cohen, 1990, Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group), Am J Cardiol, 66, 1287, 10.1016/0002-9149(90)91155-Y
van Es, 2002, Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial, Lancet, 360, 109, 10.1016/S0140-6736(02)09409-6
Brouwer, 2002, Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial, Circulation, 106, 659, 10.1161/01.CIR.0000024408.81821.32
Huynh, 2001, Aspirin, warfarin, or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery, Circulation, 103, 3069, 10.1161/01.CIR.103.25.3069
2001, Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina, J Am Coll Cardiol, 37, 475, 10.1016/S0735-1097(00)01118-9
Anand, 1998, Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: organization to assess strategies for ischemic syndromes (OASIS) pilot study results, Circulation, 98, 1064, 10.1161/01.CIR.98.11.1064
Hurlen, 2002, Warfarin, aspirin, or both after myocardial infarction, N Engl J Med, 347, 969, 10.1056/NEJMoa020496
Williams, 1997, Progression of the culprit lesion in unstable coronary artery disease with warfarin and aspirin versus aspirin alone: preliminary study, J Am Coll Cardiol, 30, 364, 10.1016/S0735-1097(97)00153-8
Zibaeenezhad, 2004, Warfarin and aspirin versus aspirin alone in patients with acute myocardial infarction: a pilot study, Angiology, 55, 17, 10.1177/000331970405500103
Anderson, 2007, Circulation, 116, e148
Antman, 2004, ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Circulation, 110, e82